145 related articles for article (PubMed ID: 12007943)
1. Brachytherapy of glioblastoma recurring in previously irradiated territory: predictive value of tumor volume.
Simon JM; Cornu P; Boisserie G; Hasboun D; Tep B; Hardiman C; Valery CA; Delattre JY; Dormont D; Baillet F; Mazeron JJ
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):67-74. PubMed ID: 12007943
[TBL] [Abstract][Full Text] [Related]
2. [Iridium 192 brachytherapy of supra-tentorial high grade glioma recurring in irradiated areas: technique and preliminary results of the Pitié-Salpêtrière hospital group].
Boisserie G; Cornu P; Dormont D; Sahel M; Hardiman C; Tep B; Mandin AM; Barret C; Faillot T; Delattre JY; Monjour A; Poisson M; Marsault C; Philippon J; Simon JM; Baillet F; Mazeron JJ
Bull Cancer Radiother; 1996; 83(3):144-52. PubMed ID: 8977564
[TBL] [Abstract][Full Text] [Related]
3. CT-guided interstitial HDR brachytherapy for recurrent glioblastoma multiforme. Long-term results.
Tselis N; Kolotas C; Birn G; Röddiger S; Filipowicz I; Kontova M; Fountzilas G; Selviaridis P; Baltas D; Heyd R; Anagnostopoulos G; Zamboglou N
Strahlenther Onkol; 2007 Oct; 183(10):563-70. PubMed ID: 17896088
[TBL] [Abstract][Full Text] [Related]
4. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
[TBL] [Abstract][Full Text] [Related]
5. Low-dose rate stereotactic iodine-125 brachytherapy for the treatment of inoperable primary and recurrent glioblastoma: single-center experience with 201 cases.
Kickingereder P; Hamisch C; Suchorska B; Galldiks N; Visser-Vandewalle V; Goldbrunner R; Kocher M; Treuer H; Voges J; Ruge MI
J Neurooncol; 2014 Dec; 120(3):615-23. PubMed ID: 25151509
[TBL] [Abstract][Full Text] [Related]
6. CT-guided interstitial HDR-brachytherapy for recurrent glioblastoma multiforme: a 20-year single-institute experience.
Chatzikonstantinou G; Zamboglou N; Archavlis E; Strouthos I; Zoga E; Milickovic N; Hilaris B; Baltas D; Rödel C; Tselis N
Strahlenther Onkol; 2018 Dec; 194(12):1171-1179. PubMed ID: 30203110
[TBL] [Abstract][Full Text] [Related]
7. Effects of iodine-125 brachytherapy on the proliferative capacity and histopathological features of glioblastoma recurring after initial therapy.
Siddiqi SN; Provias J; Laperriere N; Bernstein M
Neurosurgery; 1997 May; 40(5):910-7; discussion 917-8. PubMed ID: 9149248
[TBL] [Abstract][Full Text] [Related]
8. Accelerated hyperfractionated radiotherapy in supratentorial malignant astrocytomas.
Genc M; Zorlu AF; Atahan IL
Radiother Oncol; 2000 Aug; 56(2):233-8. PubMed ID: 10927143
[TBL] [Abstract][Full Text] [Related]
9. Interstitial iridium-192 implantation for malignant brain tumours. Part II: Clinical experience.
Chun M; McKeough P; Wu A; Kasdon D; Heros D; Chang H
Br J Radiol; 1989 Feb; 62(734):158-62. PubMed ID: 2538197
[TBL] [Abstract][Full Text] [Related]
10. Brachytherapy: Results of two different therapy strategies for patients with primary glioblastoma multiforme.
Koot RW; Maarouf M; Hulshof MC; Voges J; Treuer H; Koedooder C; Sturm V; Bosch DA
Cancer; 2000 Jun; 88(12):2796-802. PubMed ID: 10870063
[TBL] [Abstract][Full Text] [Related]
11. Implant volume as a prognostic variable in brachytherapy decision-making for malignant gliomas stratified by the RTOG recursive partitioning analysis.
Videtic GM; Gaspar LE; Zamorano L; Stitt LW; Fontanesi J; Levin KJ
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):963-8. PubMed ID: 11704318
[TBL] [Abstract][Full Text] [Related]
12. Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme.
Larson DA; Suplica JM; Chang SM; Lamborn KR; McDermott MW; Sneed PK; Prados MD; Wara WM; Nicholas MK; Berger MS
Neuro Oncol; 2004 Apr; 6(2):119-26. PubMed ID: 15134626
[TBL] [Abstract][Full Text] [Related]
13. Iridium-192 transperineal interstitial brachytherapy for locally advanced or recurrent gynecological malignancies.
Gupta AK; Vicini FA; Frazier AJ; Barth-Jones DC; Edmundson GK; Mele E; Gustafson GS; Martinez AA
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1055-60. PubMed ID: 10192355
[TBL] [Abstract][Full Text] [Related]
14. Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas.
Leibel SA; Gutin PH; Wara WM; Silver PS; Larson DA; Edwards MS; Lamb SA; Ham B; Weaver KA; Barnett C
Int J Radiat Oncol Biol Phys; 1989 Dec; 17(6):1129-39. PubMed ID: 2557303
[TBL] [Abstract][Full Text] [Related]
15. Outcome and toxicity profile of salvage low-dose-rate iodine-125 stereotactic brachytherapy in recurrent high-grade gliomas.
Schwartz C; Romagna A; Thon N; Niyazi M; Watson J; Belka C; Tonn JC; Kreth FW; Nachbichler SB
Acta Neurochir (Wien); 2015 Oct; 157(10):1757-64; discussion 1764. PubMed ID: 26298594
[TBL] [Abstract][Full Text] [Related]
16. Permanent iodine-125 interstitial implants for the treatment of recurrent glioblastoma multiforme.
Patel S; Breneman JC; Warnick RE; Albright RE; Tobler WD; van Loveren HR; Tew JM
Neurosurgery; 2000 May; 46(5):1123-8; discussion 1128-30. PubMed ID: 10807244
[TBL] [Abstract][Full Text] [Related]
17. Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme.
Chen AM; Chang S; Pouliot J; Sneed PK; Prados MD; Lamborn KR; Malec MK; McDermott MW; Berger MS; Larson DA
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):825-30. PubMed ID: 17512132
[TBL] [Abstract][Full Text] [Related]
18. Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial.
Fitzek MM; Thornton AF; Rabinov JD; Lev MH; Pardo FS; Munzenrider JE; Okunieff P; Bussière M; Braun I; Hochberg FH; Hedley-Whyte ET; Liebsch NJ; Harsh GR
J Neurosurg; 1999 Aug; 91(2):251-60. PubMed ID: 10433313
[TBL] [Abstract][Full Text] [Related]
19. What is the value of emission tomography studies in patients with a primary glioblastoma multiforme treated by 192Ir brachytherapy?
Koot RW; Habraken JB; Hulshof MC; Paans AM; Bosch DA; Pruim J
Acta Neurochir (Wien); 2008 Apr; 150(4):345-9. PubMed ID: 18278573
[TBL] [Abstract][Full Text] [Related]
20. GliaSite brachytherapy boost as part of initial treatment of glioblastoma multiforme: a retrospective multi-institutional pilot study.
Welsh J; Sanan A; Gabayan AJ; Green SB; Lustig R; Burri S; Kwong E; Stea B
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):159-65. PubMed ID: 17331666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
